Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $596000.0.

  • iBio's Net Cash Flow rose 11475.61% to $596000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $21.7 million, marking a year-over-year increase of 59569.96%. This contributed to the annual value of -$5.6 million for FY2025, which is 18283.82% down from last year.
  • Latest data reveals that iBio reported Net Cash Flow of $596000.0 as of Q4 2025, which was up 11475.61% from $19.5 million recorded in Q3 2025.
  • In the past 5 years, iBio's Net Cash Flow ranged from a high of $19.5 million in Q3 2025 and a low of -$17.7 million during Q4 2021
  • For the 5-year period, iBio's Net Cash Flow averaged around -$3.1 million, with its median value being -$3.0 million (2023).
  • Per our database at Business Quant, iBio's Net Cash Flow crashed by 47617.69% in 2024 and then skyrocketed by 71668.77% in 2025.
  • Quarter analysis of 5 years shows iBio's Net Cash Flow stood at -$17.7 million in 2021, then skyrocketed by 32.48% to -$11.9 million in 2022, then surged by 94.13% to -$701000.0 in 2023, then crashed by 476.18% to -$4.0 million in 2024, then surged by 114.76% to $596000.0 in 2025.
  • Its Net Cash Flow stands at $596000.0 for Q4 2025, versus $19.5 million for Q3 2025 and $3.6 million for Q2 2025.